Study: Omicron evades some but not all monoclonal antibodies
Por um escritor misterioso
Descrição
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
COVID-19 breakthrough infections and the omicron variant: What to know now
Omicron Is WHO's Fifth Variant of Concern, Experts Urge Patience
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
New omicron subvariant largely evades neutralizing antibodies
Omicron variant evolution on vaccines and monoclonal antibodies
Covid-19] Omicron : resistant to most monoclonal antibodies but neutralized by a booster dose
Dominant Omicron Subvariants Better at Evading Vaccines, Antibody Treatments
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
